Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01150422
Other study ID # 6.4
Secondary ID
Status Completed
Phase Phase 3
First received May 7, 2010
Last updated April 29, 2011
Start date April 2010
Est. completion date April 2011

Study information

Verified date April 2011
Source Gynuity Health Projects
Contact n/a
Is FDA regulated No
Health authority Vietnam: Scientific Committee, Hung Vuong HospitalVietnam: Scientific Committee, Health Committee of HCMC
Study type Interventional

Clinical Trial Summary

This trial will compare the efficacy and acceptability of post-medical abortion follow-up by assigning women to either 1) alternative follow-up via routine semi-quantitative pregnancy test and a self-administered follow-up questionnaire, or 2) the standard of care: a routine follow-up visit including a bimanual exam and vaginal ultrasound.

The goal of the study is to provide answers to the following questions:

1. Is a follow-up protocol that employs a self-administered questionnaire and at home use of a semi-quantitative pregnancy test effective at identifying women with ongoing pregnancies?

2. Is an innovative follow-up protocol more acceptable to women and providers than the current standard of care?

3. Is an innovative follow-up protocol feasible to implement in abortion services in Vietnam?


Recruitment information / eligibility

Status Completed
Enrollment 1500
Est. completion date April 2011
Est. primary completion date April 2011
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 13 Years to 55 Years
Eligibility Inclusion Criteria:

- Reproductive age women seeking medical abortion services

- Intrauterine pregnancy less than or equal to 63 days gestation on the day of mifepristone administration

- Hold a working, personal phone number

- be willing and able to sign consent forms and agree to comply with study procedures

Exclusion Criteria:

- Pregnancy greater than 63 days gestation on the day of mifepristone administration

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research


Related Conditions & MeSH terms


Intervention

Other:
Alternative follow-up
After mifepristone administration, women will be provided with a second semi-quantitative pregnancy test and a self-administered checklist. Women will be instructed to complete the checklist and perform the pregnancy test at home on an assigned data two weeks after mifepristone administration. On the assigned date, women will also be contacted by phone by the clinic staff. Women will be asked to confirm whether they completed the pregnancy test and checklist and asked to report on the results of both tests. Provider will review the women's responses to the checklist and confirm whether, based on the woman's responses, she should return for a follow up visit. During the follow-up phone call, women will also be asked about the satisfaction and acceptability of the alternative follow-up procedure.

Locations

Country Name City State
Vietnam Hanoi Ob-Gyn Hospital Hanoi
Vietnam National Ob-Gyn Hospital Hanoi
Vietnam HocMon District Hospital Ho Chi Minh City
Vietnam Hung Vuong Hospital Ho Chi Minh City

Sponsors (1)

Lead Sponsor Collaborator
Gynuity Health Projects

Country where clinical trial is conducted

Vietnam, 

Outcome

Type Measure Description Time frame Safety issue
Primary Continued, ongoing pregnancy 9 months No
Secondary percentage of women who return for follow-up 9 months No
Secondary percentage of women receiving other treatment for ongoing pregnancy 9 months No
See also
  Status Clinical Trial Phase
Not yet recruiting NCT02745093 - Medical Abortion at Gestational Age of 8 to ≤9 Weeks Versus >9 to ≤12 Weeks Phase 4
Completed NCT02570204 - Self-Assessment of Medical Abortion Outcome Using Serial Multi-level Pregnancy Tests N/A
Completed NCT01487213 - Routine Follow-up Versus Self-assessment in Medical Abortion N/A
Terminated NCT05119439 - Mifepristone and Two Doses of Misoprostol for Abortion at 11&12 Weeks Phase 4
Terminated NCT04941443 - Methadone and Medication Abortion Phase 4
Completed NCT02985229 - Acceptability and Feasibility of Medical Abortion in Singapore Phase 3
Completed NCT01920022 - Quickstart of Nexplanon® at Medical Abortion Phase 4
Completed NCT00472394 - Determining Women's Preferences for Medical Abortion Using Willingness to Pay N/A
Completed NCT03604341 - Cannabinoids for Pain Control During Medical Abortion Phase 4
Completed NCT00907725 - Does Follow-up With Serum Beta Human Chorionic Gonadotropin (BhCG) Simplify Medical Abortion? N/A
Completed NCT00120224 - De-Medicalizing Mifepristone Medical Abortion N/A
Completed NCT03148587 - Medical Abortion Self-Confirmation (MASC) N/A
Completed NCT00621543 - Insertion of an Intrauterine Device (IUD) After Medical Abortion N/A
Completed NCT02343913 - Simplifying Menstrual Regulation (MR): Post Abortion Care in Pakistan N/A
Completed NCT01856777 - Effectiveness of Pregnancy Tests as an Assessment Tool to Identify Continuing Pregnancy N/A
Recruiting NCT00920465 - Treatment Regimens for Mifegyne and Cytotec Phase 3
Completed NCT05532085 - Assessment of Pain During an Abortion With Knowledge of the Predictive Factors of Pain.
Completed NCT00997347 - The Extended Gestational Age Medical Abortion Study Phase 4
Completed NCT03014193 - Simplifying First Trimester Medical Abortion Follow-up N/A
Recruiting NCT04905251 - Effectiveness and Safety of Combination Mifepristone/Misoprostol for Medical Abortion